Stuart Kushon services as our Chief Scientific Officer. Prior to joining Neoteryx, Dr. Kushon, was the Senior Scientist responsible for sample preparation product development at Phenomenex starting in early 2011. At Phenomenex
he was...
James Rudge serves as our Technical Director. Prior to joining Neoteryx, Dr. Rudge worked for Phenomenex for 14 years and is a co-inventor of the Mitra Microsampling Device and the Volumetric Absorptive...
Loc Huynh, RAC, is the Regulatory Affairs and Quality Director for Neoteryx. Before joining our team in 2019, he worked for several pharmaceutical firms as a chemist, honing his attention to detail and appreciation for complex lab workflow processes...
Read Full Bio
Nima Vazin has served as the Corporate Controller since August of 2017. Prior to joining Neotreyx, Mr. Vazin was the Finance Manager at Phenomenex, where he oversaw all global finance activities...
Doug McCrory has served as Director of Sales at Neoteryx since March 2020. Prior to joining Neoteryx, Mr. McCrory worked at Phenomenex for 32 years. Mr. McCrory held a number of roles during his many years at Phenomenex, including...
Faye Salim has served as our Purchasing Director since June 2018. Prior to joining Neoteryx, Ms. Salim was the Purchasing Manager at Phenomenex, where she led a team of ten buyers. During her tenure at Phenomenex and Neoteryx, she has executed countless...
Minna Salonen has served as Neoteryx’s European Business Development Director since January 2016. Before joining Neoteryx, Ms. Salonen spent 12 years honing her business development skills in the scientific
field working for...
Neoteryx delivers on the promise of blood microsampling innovation. We are focused on delivering simple, quantitative microsampling solutions for biological samples, amenable to downstream automation. Our customers work to advance pharmaceutical development, personalized medicine, biotechnology research and clinical diagnostics.
Who is Neoteryx? | VideoOur class I exempt medical device, The Mitra® microsampler, is based on Volumetric Absorptive Microsampling (VAMS™) technology. It facilitates convenient specimen collection and transportation of blood and other biological fluids to improve animal and patient welfare, reduce laboratory costs, and enable new value-based, patient-centered models of care.
Incubated at Phenomenex for four years, the research and development of Volumetric Absorptive Microsampling (VAMS™) technology occurred with the cooperation of global pharmaceutical companies. VAMS simplifies the collection, storage, and transportation of blood samples through the instrument known as the Mitra® Microsampling Device, introduced by Neoteryx in 2014. Mitra devices accurately collect microliters of biological fluid in seconds, without volumetric blood hematocrit bias.
A chat over the limitations of Dried Blood Spot (DBS) cards between Dr. James Rudge (Phenomenex) and Dr. Neil Spooner (GlaxoSmithKline) reveals the market potential for a next generation dried blood microsampling technology.
10 µL devices based on VAMS™ technology are thoroughly tested by five leading pharmaceutical organizations, validating that they collect fixed volumes of blood while eliminating the volumetric hematocrit bias associated with DBS cards. Neoteryx is born!
As a CE-IVD registered device, Neoteryx is prepared to introduce the in vitro diagnostic European market to next generation dried blood collection and transportation.
Neoteryx expands into the United Kingdom to better serve its growing European customer base.
The Mitra® microsampler is listed as an FDA Class 1 exempt medical device.
Responding to customer demand for a higher-volume specimen, Neoteryx releases 20 µL Mitra® microsamplers.
Manufacturing expands into a new building - Neo 2 - to better accommodate the growing need to manufacture more of this technology.
Mitra® devices gain wider acceptance through projects by some of the biggest names health, research, and medicine - Quest Diagnostics, Charles River Labs, Exagen Diagnostics, and Duke University, to name a few.
With the release of the 30 µL tips, users of Mitra® devices now collect more blood. This facilitates detection of analytes with low blood concentrations and multiplex analyses from one sampler tip.
Increasing awareness of the VAMS™ advantage leads to a host of groundbreaking research. including breakthroughs in measuring HbA1c in diabetic patients, advances in therapeutic drug monitoring and clinical trials, and opening new care pathways in remote patient monitoring.
To further meet the needs of the European market, Neoteryx opens Neoteryx B.V. in Maastricht, the Netherlands.
At only five years old, VAMS™ rides a wave of commercial and academic interest to rack up its 65th publication.
Increased use of microsampling in patient monitoring drives exploration of new health and wellness applications, with a focus on drug and alcohol testing.
CEO
Founder and CEO of Neoteryx, Fasha Mahjoor obtained his undergraduate degree from Manchester Metropolitan University in the UK, and his Masters degree from the University of Southern California (USC) in architecture.
After two years in architecture practice, he was taken by the entrepreneurial spirit - in 1982, he founded Phenomenex, a global leader in separation sciences / chromatography.
Under his leadership and without any form of funding, the company rocketed to a market-leading position with 800+ employees, subsidiary companies in 16 countries, and a network of 60 international distributors.
Phenomenex has been recognized for both scientific innovation, including nine R&D 100 Awards, and a vibrant company culture as acknowledged by the Wall Street Journal and Winning Workplaces. For his leadership in the progress of science, Fasha was named to The Power List 2013 (The Analytical Scientist) recognizing the top influencer's in the field of analytical sciences.
In 2016, Fasha elected to sell his company to Danaher Corporation and stayed on as President of Phenomenex until July 2017 to ensure a smooth transition. Now, Fasha serves as CEO of Neoteryx LLC. Fasha is a noted philanthropist - he received an Ellis Island Medal of Honor in May 2013, from The National Ethic Coalition of Organizations (NECO), for his dedication to humanity.
Fasha sits on the board of directors for the American Red Cross (Los Angeles) and The Outward Bound Trust, UK as well as PharmaFluidics (Belgium).
Chief Scientific Officer
Stuart Kushon has served as our R&D Manager since July 2014. Prior to joining Neoteryx, Dr. Kushon, was the Senior Scientist responsible for sample preparation product development at Phenomenex starting in early 2011.
At Phenomenex he was the principal investigator and project lead for the Mitra Microsampling Device along with a series of sample preparation and high performance liquid chromatography (HPLC) product offerings.
Prior to that he served as the Manager of Chemistry R&D at a startup where he directed the development of products (both instruments and assays) using a novel fluorescence detection platform and a rapid immunoassay platform for medical, biodefense, and high throughput drug discovery applications.
He has been an Adjunct Professor at Saddleback College and has taught General, Organic, and Bioorganic chemistry. He acquired his Ph. D. in chemistry from Carnegie Mellon University where he studied the thermodynamics and kinetics of binding of small molecules, oligonucleotides, and their analogues.
Director of Marketing
Cathy Cordova has served as our Director of Marketing since July 2014. Prior to joining Neoteryx, Ms. Cordova led the Brand Management and Global Marketing teams for Phenomenex.
During her 12 year marketing tenure at Phenomenex, Ms. Cordova and her team successfully commercialized dozens of separation science products into the pharmaceutical, life science, clinical diagnostic, food, and environmental industries globally.
She has extensive experience in strategic marketing, business development, branding, digital marketing, website development, marketing communications, market research, media relations, and advertising.
Ms. Cordova holds a Bachelor of Science in Biochemical Engineering from University of California, Los Angeles and a Masters Degree in Business Administration from California State University, Long Beach.
Technical Director
James Rudge has served as our Technical Director since January of 2015. Prior to joining Neoteryx, Dr. Rudge worked for Phenomenex for 14 years and is a co-inventor of the Mitra Microsampling Device and the Volumetric Absorptive Matrix Sampling (VAMS) technology.
During his 14 years at Phenomenex, Dr. Rudge held a number of roles including Key Account Manager, Field Service Specialist and latterly European Business Development manager for Clinical.
These roles allowed him to collaborate with customers on a wide range of projects regularly working in customer laboratories (globally) developing novel sample preparation and LC / LCMS methods.
Dr. Rudge graduated from the University Wales, Swansea with a BSc. (Hons) IIi in Biochemistry and a Ph.D. in Organic Chemistry where he worked on novel chemiluminescent probes for immunoassays.
Director of Business Development
David Grossman joined Neoteryx in 2018 with a strong a background in managing, training, and leading sales teams to launch disruptive healthcare technologies.
Mr. Grossman has won various awards for his work, including President’s Club, Rookie of the Year, Rep of the Year, and other sales achievements as a Senior Sales Manager and Sales Training Manager. Prior to his work with Neoteryx, Mr. Grossman helped launch a genetic test that assisted in the identification of potentially harmful pathogens in patients with chronic wounds.
David holds a Masters Degree from Liberty University with a focus on Business Management and Leadership, and earned his Bachelors degree from Liberty University in Communications Studies.
Regulatory Affairs and Quality Director
Loc Huynh, RAC, is the Regulatory Affairs and Quality Director for Neoteryx. Before joining our team in 2019, he worked for several pharmaceutical firms as a chemist, honing his attention to detail and appreciation for complex lab workflow processes.
Loc comes from a rich background developed in a variety of industries, including pharma, cosmetics, dietary supplements, and consumer goods as well as medical devices. He has held positions as a Senior GxP Auditor, Quality and Regulatory Compliance Manager, and more.
With a Regulatory Affairs Certificate from the Regulatory Affairs Professional Society (RAPS), along with a bachelor’s in biochemistry from UCLA and a master’s in regulatory affairs from San Diego State University, Loc is well qualified to keep Neoteryx running on track, on schedule, and by the book.
Corporate Controller
Nima Vazin has served as the Corporate Controller since August of 2017. Prior to joining Neotreyx, Mr. Vazin was the Finance Manager at Phenomenex, where he oversaw all global finance activities.
During his 22-year finance tenure at Phenomenex, Mr. Vazin was responsible for a number of external audits, establishing many internal control protocols while overseeing the financial activities of ten Phenomenex entities.
He has extensive experience in audit, tax, treasury, financial accounting, establishing policies and procedures, establishing internal controls, and compliance reporting
Mr. Vazin holds a Bachelor of Arts in Business Administration with a concentration in Accounting.
Director of Sales
Doug McCrory has served as Director of Sales at Neoteryx since March 2020. Prior to joining Neoteryx, Mr. McCrory worked at Phenomenex for 32 years.
Mr. McCrory held a number of roles during his many years at Phenomenex, including Technical Sales Consultant, Sales Manager and Vice President of Sales.
During Mr. McCrory’s tenure at Phenomenex, his leadership helped the company become a global market leader in separation sciences / chromatography. With a sales team of 225 + employees, subsidiaries in 16 countries, and a network of 60 international distributors, Phenomenex has been recognized as an innovator in science, sales and marketing.
Mr. McCrory holds a Bachelor of Science degree from Salisbury University.
Director of Purchasing
Faye Salim has served as our Purchasing Director since June 2018. Prior to joining Neoteryx, Ms. Salim was the Purchasing Manager at Phenomenex, where she led a team of ten buyers.
During her tenure at Phenomenex and Neoteryx, she has executed countless cost reduction projects and led several Enterprise Resource Planning (ERP) initiatives to streamline purchasing and operations.
Ms. Salim has worked in the procurement field in various roles since 1990. She has extensive experience in negotiations, operations management, best practices, inventory control and purchasing.
Ms. Salim holds a Bachelor of Business Administration from University of Southern California.
European Business Development Director
Minna Salonen has served as Neoteryx’s European Business Development Director since January 2016. Before joining Neoteryx, Ms. Salonen spent 12 years honing her business development skills in the scientific field working for distributors in the chromatography industry, including several years with Phenomenex (Nordic Office), the leader in separation sciences.
Ms. Salonen has held a number of roles throughout her career, including Product Manager, Technical Sales Consultant, and Business Development Manager. She has extensive experience in strategic planning, nurturing business opportunities, contract negotiations, and managing relationships with channel partners.
During her time with Neoteryx, she and her team have developed and executed numerous strategic business opportunities across several industry verticals, regions and cultures in Europe. She and her team also have expanded the company’s network of international distributors.
Ms. Salonen holds a Master of Science degree in analytical chemistry from Jyvaskyla University, Finland. She is fluent in English, Finnish, and Swedish.
421 Amapola Ave
Torrance, CA 90501
Call us: 1 (310) 787-8747
info@neoteryx.com